Literature DB >> 15690833

Physician practices for prescribing supplemental oxygen in the palliative care setting.

Elizabeth Stringer1, Colm McParland, Paul Hernandez.   

Abstract

Dyspnea is a disturbing symptom frequently experienced by patients with advanced cancer. Supplemental oxygen is commonly used as palliative treatment in this setting. We undertook a telephone survey of physicians authorized to prescribe home oxygen according to eligibility criteria determined by publicly funded home care service. A clinical case was varied by addition of one to four factors: presence or absence of dyspnea, hypoxemia, private insurance, and a "dummy" factor to give 20 scenarios. Respondents decided whether to prescribe oxygen and rated degree of benefit oxygen would provide. Physician response rate was 81%. Respondents were in complete agreement in 44% of scenarios. The presence of breathlessness or hypoxemia affected the decision to prescribe oxygen; availability of private insurance did not. There was a wide range of perceived benefits to oxygen prescription. In conclusion, physician practices for prescribing supplemental oxygen in the palliative care setting are variable. Further research is needed.

Entities:  

Mesh:

Year:  2004        PMID: 15690833

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  5 in total

Review 1.  Management of dyspnea in patients with chronic obstructive pulmonary disease.

Authors:  Amy P Abernethy; Hope E Uronis; Jane L Wheeler; David C Currow
Journal:  Wien Med Wochenschr       Date:  2009-12

2.  Patients' experience of oxygen therapy and dyspnea: a qualitative study in home palliative care.

Authors:  Darin Jaturapatporn; Erica Moran; Chris Obwanga; Amna Husain
Journal:  Support Care Cancer       Date:  2010-03-21       Impact factor: 3.603

3.  Humidified high-flow nasal oxygen utilization in patients with cancer at Memorial Sloan-Kettering Cancer Center.

Authors:  Andrew S Epstein; Sidonie K Hartridge-Lambert; Judson S Ramaker; Louis P Voigt; Carol S Portlock
Journal:  J Palliat Med       Date:  2011-05-20       Impact factor: 2.947

Review 4.  Palliative management of refractory dyspnea in COPD.

Authors:  Hope E Uronis; David C Currow; Amy P Abernethy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 5.  Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis.

Authors:  H E Uronis; D C Currow; D C McCrory; G P Samsa; A P Abernethy
Journal:  Br J Cancer       Date:  2008-01-08       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.